BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
Get Our Industry eNewsletter FREE email:    
Biotech/Pharma - Patent News
Salix Pharmaceuticals, Ltd. (SLXP) Secures Additional Intellectual Property Relating To Rifaximin 9/18/2014
Biostar Pharmaceuticals, Inc. (BSPM) Files A PRC Patent Application For Oleanolic Acid Injection, Its New Drug Product For Hepatitis B And Liver Cancer 9/18/2014
Biocept, Inc. (BIOC) Granted Patent In China For Its Microfluidic Channel Technology Used To Capture Circulating Tumor Cells 9/18/2014
Patent Position Of Merus' MeMo® Mouse Strengthened by Ruling of European Patent Office 9/18/2014
Regen BioPharma Files Patent Application On New Therapy That Uses the "Innate" Immune System To Kill Cancer 9/17/2014
Spectrum Pharmaceuticals, Inc. (SPPI) Announces Issue Of A New Patent For Beleodaq™ (Belinostat) For Injection With Patent Term Adjustment Till 2027 9/16/2014
Trevena, Inc. (TRVN) Granted Key U.S. Composition Of Matter Patent For TRV130 9/16/2014
Advanced Medical Isotopes Corporation Licensed Brachytherapy Seed Patent Granted 9/16/2014
Oculus Innovative Sciences, Inc. (OCLS) Strengthens Intellectual Property Portfolio With Allowance Of Four New Patents For Microcyn® Technology 9/16/2014
Galectin Therapeutics Announces Issuance Of U.S. Patent For GR-MD-02 In Diabetic Nephropathy 9/15/2014
Dyax Corp. (DYAX) Announces Issuance Of Two Key U.S. Patents For DX-2930 9/15/2014
Marina Biotech, Inc. (MRNA) Announces The Continued Worldwide Expansion Of Its Delivery Technology Intellectual Property Estate 9/15/2014
NeoStem, Inc. Announces Licensing Of Patent Portfolio From The Rockefeller University Expanding Its Cancer Immunotherapy Intellectual Property Portfolio 9/11/2014
Marrone Bio Innovations Receives Patent For Use Of Chromobacterium To Control Corn Rootworm Larvae Infestation 9/11/2014
Lakewood-Amedex Inc. Receives Notice Of Allowance From The United States Patent and Trademark Office (USPTO) For A New Patent Covering Its nanoRNA Gene-Silencing Technology 9/11/2014
Egalet Announces Issuance Of U.S. Patents Covering Guardian™ Technology And Product Candidates 9/11/2014
Flexion Therapeutics (FLXN) Announces Issuance Of U.S. Composition Of Matter Patent For Lead Candidate FX006 9/9/2014
Gentag, Inc.'s Disposable NFC Biomarker Patent Receives Notice Of Allowance From The European Patent Office 9/9/2014
GenSpera Receives Patent On Prodrug Targeted For Prostate Cancer 9/9/2014
Mersana Therapeutics, Inc. Strengthens Antibody-Drug Conjugate Intellectual Property Position With Issuance Of Three Additional U.S. Patents 9/9/2014
BerGenBio AS Granted Platform Patent - Cellselect™ Platform Also Described In Peer-Reviewed Journal 9/8/2014
Argos Therapeutics, Inc. (ARGS) Announces Issuance Of Arcelis® Technology Platform Patent 9/8/2014
Advanced Cell Technology Announces Issuance Of Patent Covering Dendritic Cells Manufacturing From Renewable Stem Cell Sources 9/5/2014
Can-Fite BioPharma (CFBI) Issued Japanese Patent For CF102 In The Treatment Of Liver Regeneration And Function Following Surgery 9/5/2014
Alitair Pharmaceuticals Receives A U.S. Composition Of Matter Patent For Benzonatate Polacrilex 9/5/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance of Fourth US Patent Protecting Oxtellar XR® 9/4/2014
KineMed, Inc. Receives U.S. Patent Allowance For Noscapine To Treat ALS, Parkinson’s Disease, And Diabetic Neuropathy 9/4/2014
Clearside Biomedical Announces Fourth Patent Allowance In The U.S. Related To Proprietary Microneedle Drug Delivery Methods And Devices 9/4/2014
Rexahn Pharmaceuticals, Inc. (RNN) Receives A Notice Of Allowance From The U.S. Patent And Trademark Office For A Novel Targeted Cancer Drug Delivery Platform 9/3/2014
Suven Life Sciences Ltd Secures (3) Product Patents For Their NCEs In South Korea, China And Canada 9/3/2014
Orexigen Therapeutics, Inc. (OREX) Expands NB32 Intellectual Property Portfolio With New U.S. Patent 9/3/2014
DelMar Pharmaceuticals Receives Notice Of Allowance For Second U.S. Patent For VAL-083 9/3/2014
United States Patent & Trademark Office Issues Three New Standard Essential Patents To Spherix (SPEX) 9/2/2014
Cellular Dynamics International Awarded U.S. Patent Covering Automated Production Of All Human Pluripotent Stem Cells 8/29/2014
United Therapeutics Corporation (UTHR) Release: District Court Decision Received In Remodulin Patent Case 8/29/2014
iBio, Inc. (IBIO) Receives European Patent Allowances For Protein Expression Technology 8/28/2014
Onxeo Strengthens Beleodaq® Patent Protection In The U.S. Until 2027 8/28/2014
TxCell Granted Five New Patents In Major Global Territories For Core Technology And Astria Platform Since January 2014 8/27/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of An Additional Notice Of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 8/27/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating, Double-Stranded Molecules Of 19 To 52 Nucleotides In Length 8/27/2014
Ryogen LLC Awarded Two U.S. Patents Directed To Hepatitis C And Diabetes 8/27/2014
Actavis (ACT) Confirms Generic Neupro® Patent Challenge 8/25/2014
MultiCell Technologies Inc. (MCET.OB) Granted U.S. Patent Covering Therapeutics Which Fight Virus Infection And Cancer 8/25/2014
Dicerna Pharmaceuticals (DRNA) Announces The Issuance Of Multiple Patents Covering Claims For Dicer Substrate SiRNAs 8/21/2014
BioLineRx Ltd. Receives Notice Of Allowance For U.S. Patent On BL-7010 Covering Use Of Novel Polymer In Prevention Of Gluten Toxicity 8/21/2014
Achillion Pharmaceuticals, Inc. (ACHN) Granted U.S. Patent For ACH-3102 And Structurally Related NS5A Inhibitors 8/20/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Rnai-Mediating Double-Stranded Molecules Comprising Up To 25 Base Pairs 8/20/2014
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent in Spain For Oral Administration Of Insulin 8/19/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Further Expanding Stem Cell Technology Platform 8/19/2014
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 8/18/2014
Nodality, Inc. Expands Intellectual Property Estate, Announces U.S. Patent For Broadly Enabling Single Cell Network Profiling (SCNP) Technology Platform 8/14/2014
Access Pharmaceuticals (ACCP) Awarded Japan Patent For MuGard And ProctiGard 8/14/2014
La Jolla Pharmaceutical Company (LJPC) Receives Notice Of Allowance For Additional Patent Claims Covering Modified Pectin For The Treatment Of Chronic Inflammation 8/14/2014
Trevi Therapeutics Announces The Issuance Of Two Patents Covering The Oral Sustained Release Formulation Of Nalbuphine ER 8/14/2014
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Nonalcoholic Fatty Liver Disease 8/12/2014
eAgile Awarded Patent For RFID Intelligent Packaging Breakthrough 8/12/2014
EnGeneIC Pty Ltd Receives Patent From The USPTO For EDV™ Nanocell Technology 8/11/2014
InVivo Therapeutics Corporation (NVIV) Receives Notice Of Allowance On Patent Covering Neuro-Spinal Scaffold And Neuro-Spinal Scaffold Plus Stem Cells 8/11/2014
Extending Patent Protections To Discover The Next Life-Saving Drugs 8/11/2014
Horizon Pharma Announces The U.S. Patent And Trademark Office Issuance Of Additional Notices Of Allowance With Claims Covering VIMOVO®(Naproxen / Esomeprazole) Delayed Release Tablets 8/6/2014
Mallinckrodt Pharmaceuticals (MNK) Receives Patent From U.S. Patent And Trademark Office 8/6/2014
Suven Life Sciences Ltd Secures (2) Product Patents For Their Nces In Australia And Eurasia 8/6/2014
Islet Sciences Receives Notice Of Allowance For U.S. Patent Covering Novel IL-12 Inhibitors 8/6/2014
Menlo Park's TesoRx Locks In $10 Million, Secures Key Patent And Taps Renowned Urologist As Chief Medical Officer 8/5/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 Composition Of Matter 8/5/2014
Trevena, Inc. (TRVN) Granted Key U.S. Method Of Use Patent For TRV027 8/5/2014
United States Patent Issued To Adamas Pharmaceuticals (ADMS) 8/5/2014
CDEX Inc. (CDEX) Granted Notice Of Allowance For U.S. Patent Application Covering Identification And Determination Of Chemical Substances Using Enhanced Photoemission Spectroscopy 7/31/2014
Mystic Pharmaceuticals Receives Notice Of Allowance For Novel Powder Drug Delivery Technology 7/31/2014
Transgenomic, Inc. (TBIO) Announces Issuance Of New European Patent Covering COLD-PCR Technologies 7/31/2014
GenSpera Announces US Patent For Methods And Compositions For The Detection, Imaging And Treatment Of Cancer 7/30/2014
Ryogen LLC Awarded Two Patents Directed To Polynucleotide Sequences That Play Key Roles In Various Cancers 7/29/2014
Advaxis, Inc. Receives Notice Of Allowance For Cancer Immunotherapies Patent In Japan 7/28/2014
VGTI Florida Researcher Invents Potential Breakthrough Antiviral Compounds For Prevention Of Mosquito-Borne Illnesses 7/28/2014
MYOS (MYOS) Receives Notice Of Allowance Of U.S. Patent Application For Proprietary Manufacturing Methods Of Fortetropin 7/24/2014
Genticel Granted Five New Patents In The Us And Asia During First Half Of 2014 7/24/2014
Drawbridge Pharmaceuticals Extends Phaxan™ Patent Portfolio With Divisional Patents Granted For Other Neuroactive Steroids 7/22/2014
Opko Health, Inc. Granted Patent From U.S. Patent & Trademark Office For RAYALDEE 7/22/2014
Alnylam Pharmaceuticals (ALNY) Receives Notice Of Allowance From United States Patent And Trademark Office (USPTO) For New Patent Broadly Covering Conjugate-Based Delivery Of RNA Therapeutics 7/22/2014
U.S. Patent Office Grants McCord Research Endothelial Cell Treatment Patent 7/22/2014
Particle Sciences And Eyeon Therapeutics Receive Patent On Novel Dry Eye Technology 7/22/2014
Hepatitis C Spurs Unusual Patent Wars Among Big Drug Makers 7/21/2014
Agile Therapeutics, Inc. Announces Allowance Of Additional Patent Claims For Skinfusion® 7/18/2014
BMC To Actively Defend Against Curative In Patent Fight 7/18/2014
Integral Molecular, Inc. Announces Patent Allowance For Dengue Research Technology 7/18/2014
Columbia Laboratories, Inc. (CBRX) Expands Its Intellectual Property Portfolio Following Receipt Of U.S. Patent 7/17/2014
Lipocine Inc. (LPCN) Announces Issuance Of U.S. Patent For LPCN 1021 7/16/2014
InSite Vision (ISV) Announces The Issuance Of Broad U.S. Patent Covering Bromfenac Formulations In Durasite® 7/16/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Patent For APD371 By United States Patent And Trademark Office 7/16/2014
Prima Biomed (PRR.AX) Receives U.S. Patent Grant For CVac 7/16/2014
Kraig Biocraft Laboratories, Inc. Announces U.S. Patent And Trademark Office Has Registered The Company's Monster Silk® Trademark 7/15/2014
C4X Discovery Patent Granted In Japan 7/15/2014
BioTime (BTX) Announces Issuance Of 14 Patents In The Fields Of Regenerative Medicine, And Cancer Diagnosis And Therapy 7/14/2014
Transplant Genomics Inc. Announces Exclusive License To Patent Rights Co-Owned By The Scripps Research Institute And Northwestern University 7/14/2014
Zogenix, Inc. (ZGNX) Announces New Patent Valid Through 2032 For DosePro® Needle-Free Delivery System 7/14/2014
Actavis (ACT) Confirms Generic Diclegis® Patent Challenge 7/14/2014
Cellular Dynamics International Awarded Patents Covering Derivation Of Pluripotent Stem Cells From Fresh Or Banked Human Blood Samples 7/10/2014
Pharmalink AB's Core Patents For Nefecon® Treatment For Renal Disease Granted In United States, Europe, China And Hong Kong 7/10/2014
Rosetta Genomics Ltd. (ROSG) Receives Notice Of Allowance For U.S. Patent For The Treatment Of Ovarian Cancer 7/10/2014
Microbix Biosystems Inc. (MBXBF) Sues Novartis AG (NVS) For Infringement Of Its VIRUSMAX® Patent In Europe 7/10/2014
Palatin Technologies (PTN) Announces Notification of Patent Allowance On Melanocortin Receptor-1 Specific Peptides 7/9/2014
Alkermes plc (ALKS) Announces Notices of Allowance For U.S. Patents For Four CNS Pipeline Candidates 7/9/2014
ZS Pharma (ZSPH) Announces Allowance Of Two U.S. Patent Applications For ZS-9 7/8/2014
Sirnaomics Strengthens Its IP Position For Advancing The Company's Novel siRNA Therapeutics Programs 7/8/2014
Access Pharmaceuticals (ACCP) Awarded Hong Kong Patent For MuGard 7/8/2014
Aegis Therapeutics, LLC Awarded US Patent For Stable "Shirt-Pocket" Insulin Suitable For Metered Nasal Spray Or Injection 7/8/2014
Actavis (ACT) Confirms Generic Ampyra® Patent Challenge 7/8/2014
Seres Health Announces Allowance For Key Patent On The Use Of Synergistic Bacterial Compositions 7/7/2014
Q Therapeutics, Inc. Announces First U.S. Patent Relating To Fifth Patent Family On Neural Cells 7/7/2014
22nd Century Group, Inc. Announces Allowance of U.S. Patent For Regulating Nicotine in Tobacco Using Transcription Factor Gene 7/3/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Broad FZD-Fc Composition-Of-Matter And Use Patent In U.S. 7/2/2014
Collegium Pharmaceutical, Inc. Announces Issuance Of U.S. Patent Covering Oxycodone DETERx®, An Abuse-Deterrent, Extended-Release Opioid Product 7/2/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of Broad U.S. Patent For Neuvax™ (Nelipepimut-S) 7/1/2014
Valensa Is Granted New Patents For "Worry Free" Chia-Based Ingredients 7/1/2014
Mati Therapeutics Expands Patent Portfolio 6/30/2014
Actavis (ACT) Confirms Generic Zubsolv® Patent Challenge 6/30/2014
Premier Biomedical Announces Important Patent Award For A Potential Multi-Billion Dollar Drug For The Treatment Of Fibromyalgia And Neuralgia 6/30/2014
Orexo AB (ORXOF) Commences Patent Infringement Litigation Against Actavis (ACT) 6/27/2014
Opko Health, Inc. Granted Patent from European Patent Office For Lagova™ 6/27/2014
Regulus Therapeutics, Inc. Announces Patent Grant From U.S. Patent Office In Sarnow Patent Estate On Microrna Therapeutics For The Treatment Of HCV 6/25/2014
Shire Pharmaceuticals (SHPG) Release: Vyvanse® Patents Found To Be Infringed And Valid By U.S. District Court 6/25/2014
Ryogen LLC Is Awarded Patent For Polynucleotides Related To Tumor-Suppressing Subtransferable Candidate 4 6/24/2014
BioInvent (BOVNF) Granted U.S. Patent For BI-505 And Apoptosis-Inducing ICAM-1 Antibodies 6/24/2014
Advaxis, Inc. Receives Notice Of Allowance From U.S. Patent Office For Two Patent Applications With Multiple Claims Covering Its Cancer Immunotherapy ADXS-Cher2 6/23/2014
Perrigo Company (PRGO) Announces Settlement In Proair® HFA Patent Case 6/20/2014
Actavis (ACT) Confirms District Court Ruling In Generic Exelon® Patch Patent Suit 6/19/2014
Pluristem Therapeutics (PSTI) Granted Patent In Russia For Treatment Of Inflammatory Bowel Disease Using Placenta-Derived Cells 6/19/2014
TriLink BioTechnologies Awarded Patents For Novel Ligation Technology In US, Europe And New Zealand 6/19/2014
Drawbridge Pharmaceuticals Granted New Anaesthesia Patent For Phaxan™ In China 6/18/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of Two U.S. Patents For Zerenex(TM) Covering Orally Administrable Forms Of Ferric Citrate 6/18/2014
ProLynx Issues U.S. Patent Covering Controlled Release Drug Conjugates 6/18/2014
Patrys Limited (PAB.AX) Granted Third U.S. Patent For Lead Clinical Product PAT-SM6 6/18/2014
Forest Laboratories, Inc. (FRX) Obtains Six Months U.S. Pediatric Exclusivity for NAMENDA® and NAMENDA XR® 6/18/2014
Teva Pharmaceutical Industries Limited (TEVA) Reaches Settlements In NUVIGIL® Patent Case 6/17/2014
ArmaGen Technologies, Inc. Receives Notice Of Allowance For U.S. Patent Covering Novel Investigational Therapy For Hunter Syndrome 6/17/2014
Essentialis Announces The Grant Of Its First Japanese Patent Which Provides Extensive Protection To DCCR In The Treatment Of Prader-Willi Syndrome 6/17/2014
Pluristem Therapeutics (PSTI) Receives Patent In India For Cell Therapy Production Methods And Compositions 6/16/2014
Arrowhead Research Corporation (ARWR) Issues A Statement On Intellectual Property Protection For ARC-520 6/16/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For Canadian Patent Expanding Stem Cell Technology Platform 6/16/2014
Milan District Court Confirms The Validity Of Alfa Wasserman's Rifaximin-Alpha Patents 6/12/2014
Alnylam Pharmaceuticals (ALNY) Announces United States Patent And Trademark Office (USPTO) Issues Patent Covering Rnai Therapeutics For The Treatment Of Hepatitis B Virus (HBV) Infection 6/12/2014
Zealand Pharma  (ZEAL.CO)’s GLP-2 Analogue European Patent Rights Upheld By The European Patent Office Opposition Division 6/12/2014
Spherix (SPEX) Commences Litigation Against Verizon For Patent Infringement 6/12/2014
The United States Patent Office Grants Neol Biosolutions The Patent For The Technology Microbioil-1® 6/12/2014
Catabasis Pharmaceuticals, Inc. Announces Issuance Of Three New US Patents For CAT-1000 Series 6/11/2014
BioLineRx Ltd. Receives Notice Of Allowance For US Patent Covering Novel Treatment For Celiac Disease 6/11/2014
Stemedica Cell Technologies, Inc. Earns U.S. Patent For Cellular Scaffold Enhanced By Stem Cell Factors 6/10/2014
Palatin Technologies (PTN) Announces Notification Of Patent Allowance On Next Generation Melanocortin Receptor-Specific Peptides 6/10/2014
Titan Pharmaceuticals (TTP) Receives Notice Of Allowance For Patent Of Implantable Polymeric Device For Sustained Release Of Dopamine Agonists 6/10/2014
iBio, Inc. (IBIO) Expands IP Protection Of Biotherapeutic Product For Treatment Of Fibrosis 6/10/2014
Xenetic Biosciences Strengthens Technology Patent Portfolio 6/9/2014
Galmed Pharmaceuticals Announces The Filing Of A Provisional Patent Application For The Use Of Aramchol For The Treatment Of Lipodystrophy 6/9/2014
PharmAthene, Inc. (PIP) Granted U.S. Patent For Recombinant Bioscavenger 6/9/2014
Enzo Biochem (ENZ) Awarded U.S. Patent On More Efficient Vector For Use In Gene Therapy 6/6/2014
Marina Biotech, Inc. (MRNA) Receives Decision To Grant Japanese Patent For Its SMARTICLES Nucleic Acid Delivery Technology 6/6/2014
AMAG Pharmaceuticals, Inc. (AMAG) Announces Patent Term Extension For Ferumoxytol In The U.S. 6/6/2014
Qu Biologics Granted Broad New Zealand Patent Involving Immunotherapies Derived From Viruses For Treating A Range Of Cancers 6/5/2014
Scancell: DNA ImmunoBody Patent Granted In United States 6/5/2014
iBio, Inc. (IBIO) European Patent On iBioModulator Technology Emerges From Opposition Period 6/5/2014
Anavex Life Sciences Corp. (AVXL.OB) Awarded New U.S. Patent 6/4/2014
Suven Life Sciences Ltd Secures One Product Patent In U.S.A. 6/4/2014
Actavis (ACT) Announces Nuvigil® Patent Challenge Settlement 6/2/2014
Mylan Inc. (MYL) Settles Patent Litigation Related To Celebrex® Capsules 6/2/2014
ERYtech Pharma Strengthens Its Intellectual Property Portfolio 6/2/2014
Actavis (ACT) Confirms Generic Onglyza® Patent Challenge 5/28/2014
Galectin Therapeutics Receives U.S. Patent For GR-MD-02 In Diabetic Nephropathy, A Progressive Kidney Disease 5/28/2014
Teva Pharmaceutical Industries Limited (TEVA) Announces Favorable European Patent Office Ruling In COPAXONE® Patent Proceeding 5/28/2014
Iroko Pharmaceuticals Granted Key Patent For TIVORBEX™ 5/28/2014
Batu Biologics Files Patent Covering Its Proprietary Cancer Vaccine Targeting The Tumor Endothelium: Vallovax 5/27/2014
Hemispherx Biopharma (HEB) Receives New U.S. Composition Of Matter Patent Covering Ampligen® Formulations 5/27/2014
Prima Biomed (PRR.AX)'s CVac Patent Application Receives U.S. Notice Of Allowance 5/27/2014
Transposagen Biopharmaceuticals, Inc. Issued Key U.S. Patent Covering Rat Models Of Cancer 5/23/2014
Innovus Pharma Announces The Issuance Of A New Canadian Patent For Its Zestra® Product 5/19/2014
Suven Life Sciences Ltd Product Patents In Australia, South Korea And China 5/19/2014
Neos Therapeutics Announces Issuance Of New Patent Covering Composition Of Matter For Company’s Novel ADHD Products 5/15/2014
BioLight Announces U.S. Patent Approval For Its Formulation Of Latanoprost In Its Proprietary Controlled Release Insert For The Treatment Of Glaucoma 5/14/2014
Appethyl's U.S. Patent, "Use Of Plant Cell Membrane For The Treatment Of Obesity" Issued To Greenleaf Medical AB 5/13/2014
Batu Biologics Files Patent Covering New Use Of Approved Drug For Decreasing Cancer Immunotherapy Toxicity 5/12/2014
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In Canada 5/12/2014
Omni Bio Pharmaceutical Announces Grant Of New Use Patent In Europe 5/8/2014
Pivotal Therapeutics Inc. Announces Issuance Of U.S. Patent 8,715,648 For Its Unique 6:1 EPA:DHA Formulation 5/8/2014
Can-Fite BioPharma (CFBI) Receives Patent In European Union For Treatment Of Liver Function Following Surgery 5/8/2014
Synthetic Biologics, Inc. (SYN) Announces Recent International Patents That Bolster Its C. Difficile Program 5/8/2014
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 2nd US Patent 8,697,633 5/8/2014
Discovery Laboratories (DSCO) Expands Exclusivity Portfolio With Three New U.S. Patents 5/7/2014
Cyclacel Pharmaceuticals, Inc. (CYCC) Release: New Japanese Patents Issued Covering Sapacitabine Pharmaceutical Formulations And Combination Treatments 5/5/2014
ADial Pharmaceuticals Announces Issuance Of First U.S. Patent 5/1/2014
Alcobra (ADHD) Issued New US Patent Covering Metadoxine Use For Cognitive Disorders 5/1/2014
Curis, Inc. (CRIS) Announces U.S. Patent Issuance Covering CUDC-907 Composition-Of-Matter 4/30/2014
BioAtla Receives Broad Patent Covering Conditionally Active Biologics 4/30/2014
KemPharm, Inc. Receives Notice Of Allowance For Novel Prodrug Of Hydromorphone 4/30/2014
AVANIR Pharmaceuticals (AVNR) Prevails In NUEDEXTA Patent Trial Resulting In Exclusivity Through 2026 4/30/2014
Braasch Biotech Continues To Build Patent Portfolio With Acceptances In The European Union, Russia And Israel 4/28/2014
Epizyme (EPZM) Announces Notice Of Allowance For U.S. Patent Application Covering Methods Of Treatment For Cancers With EZH2 Inhibitors 4/24/2014
U.S. District Court Finds In Favor Of Azbil BioVigilant, Inc. In Patent Litigation Dispute 4/24/2014
Actavis (ACT) Announces Celebrex® Patent Challenge Settlement 4/24/2014
iBio, Inc. (IBIO) Receives Patent Allowance In China For Fusion Protein Compositions And Technology 4/24/2014
Premier Biomedical Receives Notice Of Allowance On Broad Base Patent 4/24/2014
VistaGen Therapeutics, Inc. Receives Notice Of Allowance For U.S. Patent Expanding Stem Cell Technology Platform For Drug Rescue And Regenerative Medicine 4/23/2014
TWi Pharmaceuticals, Inc. Announces Settlement Of Lidoderm® Patent Litigation 4/23/2014